MedPath
NMPA Approval

Cerebroprotein Hydrolysate for Injection(Ⅱ)

国药准字H20051230

April 15, 2020

Drug Information

注射用脑蛋白水解物(Ⅱ)

舒瑞泰

舒瑞泰

注射剂

30.50mg(以总氮计)

化学药品

April 15, 2020

Company Information

Applicant Company

Manufacturing Company

广东省中山市南朗镇华南现代中医药城思邈路13号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用脑蛋白水解物(Ⅱ) - NMPA 批准文号 | MedPath